Anyone with an eye on Penny Stocks in recent weeks has seen the explosive move that Amarantus Biosciences Inc. (OTC: AMBS) has been making! The stock has run from well under a Penny to recent highs of 9 cents. After a momentary shakedown to the 3 cent level AMBS has come back strong exploding to over a nickel and heavy speculation says round two comes this week!
Much of the excitement on AMBS surrounds their therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (MANF"). Amgen Co-Founder Joseph Rubinfeld who recently joined the AMBS corporate advisory board and has purchased stock of AMBS before said "I believe in MANF, I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen"
MANF is a protein that corrects protein misfolding. Protein misfolding is one of the major causes of apoptosis (cell death). This property provides a compelling rationale for the research and development of MANF-based products as therapeutics for human disease. Our lead MANF product development effort is centered on a therapy for Parkinson's disease.
AMBS Is on the rise again and speculation on the street is this one goes much higher. To find out more about this stock and what OTCMAGIC projects for Amarantus Biosciences please go here: AMBS stock
OTCMagic.com is quickly becoming the preeminent destination for up to date information on the hottest stocks in Penny stock World.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.